DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Reviewed and updated by Dr Amanda Oakley Dermatologist, Hamilton, New Zealand; Vanessa Ngan, Staff Writer, June 2014; Dr Jannet Gomez, Postgraduate Student in Clinical Dermatology, Queen Mary University London, United Kingdom, July 2016.
Erythrasma is a common skin condition affecting the skin folds under the arms, in the groin and between the toes.
Erythrasma affects males and females, but it is thought to be more common in the groin of males and between the toes of females.
It is reported to be more prevalent in the following circumstances:
The bacteria responsible for erythrasma are gram-positive, non-spore-forming, aerobic or facultative bacilli called Corynebacterium minutissimum.
Erythrasma presents as well-defined pink or brown patches with fine scaling and superficial fissures. Mild itching may be present.
The common sites for erythrasma are armpits, groin and between the toes. The intergluteal fold, submammary, and periumbilical skin may also be affected. Widespread infections are most often associated with diabetes mellitus.
Erythrasma is classified into three types according to location.
Serious complications are very rare. Corynebacteria have been reported to causes abscess, cellulitis, cutaneous granuloma, endocarditis, pyelonephritis, endophthalmitis, arteriovenous fistula infection and meningitis.
Erythrasma has a typical clinical appearance. Diagnosis may be supported by the following investigations.
Photodynamic therapy using red light (broadband, peaking at 635 nm) has also been used to treat patients with erythrasma.
Recurrence of erythrasma is common. Antibacterial soap can be used to prevent recurrence. Treatment can be repeated if necessary.
See the DermNet NZ bookstore.
© 2019 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.